Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Leggett

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Molecular and Cellular Biology|December 4, 2003
Ubiquitin depletion as a key mediator of toxicity by translational inhibitorsJohn Hanna, David S Leggett, Daniel Finley
Methods in Molecular Biology (Clifton, N.J.)|May 27, 2005
Purification of proteasomes, proteasome subcomplexes, and proteasome-associated proteins from budding yeastDavid S Leggett, Michael H Glickman, Daniel Finley
Journal of Biomolecular Screening|June 21, 2008
High-content fluorescent-based assay for screening activators of DNA damage checkpoint pathwaysBin Zhang, Xiubin Gu, Uma Uppalapati, et al.
Molecular Cell|November 1, 2002
Multiple associated proteins regulate proteasome structure and functionDavid S Leggett, John Hanna, Anna Borodovsky, et al.
Cell|October 5, 2006
Deubiquitinating enzyme Ubp6 functions noncatalytically to delay proteasomal degradationJohn Hanna, Nathaniel A Hathaway, Yoshiko Tone, et al.
Molecular Cancer Therapeutics|May 21, 2010
ARQ 197, a novel and selective inhibitor of the human c-Met receptor tyrosine kinase with antitumor activityNeru Munshi, Sébastien Jeay, Youzhi Li, et al.
Nature Cell Biology|August 29, 2002
Proteasome subunit Rpn1 binds ubiquitin-like protein domainsSuzanne Elsasser, Rayappa R Gali, Martin Schwickart, et al.
Cell|December 28, 2006
Ubiquitin chains are remodeled at the proteasome by opposing ubiquitin ligase and deubiquitinating activitiesBernat Crosas, John Hanna, Donald S Kirkpatrick, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Molecular and Cellular Biology|December 4, 2003
Ubiquitin depletion as a key mediator of toxicity by translational inhibitorsJohn Hanna, David S Leggett, Daniel Finley
Methods in Molecular Biology (Clifton, N.J.)|May 27, 2005
Purification of proteasomes, proteasome subcomplexes, and proteasome-associated proteins from budding yeastDavid S Leggett, Michael H Glickman, Daniel Finley
Journal of Biomolecular Screening|June 21, 2008
High-content fluorescent-based assay for screening activators of DNA damage checkpoint pathwaysBin Zhang, Xiubin Gu, Uma Uppalapati, et al.
Molecular Cell|November 1, 2002
Multiple associated proteins regulate proteasome structure and functionDavid S Leggett, John Hanna, Anna Borodovsky, et al.
Cell|October 5, 2006
Deubiquitinating enzyme Ubp6 functions noncatalytically to delay proteasomal degradationJohn Hanna, Nathaniel A Hathaway, Yoshiko Tone, et al.
Molecular Cancer Therapeutics|May 21, 2010
ARQ 197, a novel and selective inhibitor of the human c-Met receptor tyrosine kinase with antitumor activityNeru Munshi, Sébastien Jeay, Youzhi Li, et al.
Nature Cell Biology|August 29, 2002
Proteasome subunit Rpn1 binds ubiquitin-like protein domainsSuzanne Elsasser, Rayappa R Gali, Martin Schwickart, et al.
Cell|December 28, 2006
Ubiquitin chains are remodeled at the proteasome by opposing ubiquitin ligase and deubiquitinating activitiesBernat Crosas, John Hanna, Donald S Kirkpatrick, et al.
Pageof 1